Clinical Briefs in Primary Care
RSSArticles
-
How Long Should We Treat with Warfarin for Symptomatic Venous Thromboembolism?
Long-term anticoagulation was associated with about an 80% reduction in recurrent venous thromboembolic events compared to short-term anticoagulation.
-
Stroke Accelerates Long-term Process of Cognitive Decline
Following an acute stroke, executive function declined significantly — more steeply than in controls; encouragingly, the capacity for new learning post-stroke did not decline.
-
Extending the Window of Anticoagulation After Pulmonary Embolus
After the initial 6-month treatment of pulmonary embolus, extended anticoagulation of up to 18 months dramatically reduces risk of recurrence at the expense of more episodes of major bleeding.
-
Sound Stimulation in Alzheimer’s Patients
Music may provide meaningful clinical improvements in patients with Alzheimer's disease, as well as an enhanced quality of life.
-
An Unrecognized Relationship Between Asthma and Obesity
Weight reduction may be an overlooked tool for asthma management.
-
Oral Nutritional Supplementation for Hospitalized COPD Patients Pays Off
Favorable results should prompt reconsideration of the value — health wise and economic — of oral nutritional supplementation in patients admitted for COPD.
-
Risks of Digoxin Use in Atrial Fibrillation
The results of a recent study should prompt reconsideration of the various choices available for rate control in atrial fibrillation.
-
Dietary Fat Used to Be the Bad Guy
But the replacement of fats with refined carbohydrates is not a healthful tradeoff.
-
We’re Going to Be Hearing a Whole Lot More About Nonalcoholic Fatty Liver Disease
The dual burdens of obesity and diabetes — both of which are direct antecedents to nonalcoholic fatty liver disease — have changed the map of fatty liver disease on a global basis.
-
Beta-blocker, Shmeta-blocker…Or Are There Important Differences?
Whether clinicians should choose pharmacotherapy based on central BP effects has not been confirmed, although hypertension guidelines throughout the world have increasingly recognized the inadequacy of traditional beta-blockers in comparison to most other classes of agents and relegated them to a lower position on the therapeutic ladder.